Search results for "upper airways"

showing 4 items of 4 documents

Broncalt®, class II medical device, in patients with acute upper airways disease: a survey in clinical practice.

2019

Inflammation is a common pathogenic mechanism involved in many otorhinolaryngological (ORL) disorders. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It has been reported that it exerted a safe and effective anti-inflammatory, washing, and antimicrobial activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients with acute upper airways disease. The 3,533 (1,797 males, mean age 43.5 years) patients were evaluated at baseline (T0) and after a 2-week treatment …

AdultMaleupper airwaysAdolescentPlant ExtractsAcute disease; Grapefruit seed extract; Hyaluronic acid; Thermal water; Upper airwaysgrapefruit seed extractthermal waterWaterupper airways acute disease thermal water hyaluronic acid grapefruit seed extractNOOtolaryngologyOtorhinolaryngologic DiseasesYoung AdultTreatment OutcomeEquipment and SuppliesHealth Care SurveysAcute DiseaseSeedshyaluronic acidHumansFemaleOriginal ArticleCitrus paradisiActa bio-medica : Atenei Parmensis
researchProduct

Broncalt®, class II medical device, in patients with chronic upper airways disease: a survey in clinical practice

2019

Inflammation and infection are common pathogenic mechanisms involved in many otorhinolaryngological (ORL) chronic diseases. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients with chronic upper airways disease. The 1,817 (958 males, mean age 49 years) patients were evaluated at baseline (T0) and after one (T1) and two (T2) …

Maleupper airwaysPlant Extractsgrapefruit seed extractthermal waterWaterMiddle AgedNOOtolaryngologyOtorhinolaryngologic DiseasesTreatment OutcomeEquipment and SuppliesHealth Care SurveysSeedshyaluronic acidupper airways chronic disease thermal water hyaluronic acid grapefruit seed extractHumansOriginal ArticleFemalechronic diseaseCitrus paradisi
researchProduct

Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice.

2019

Inflammation and infection are common pathogenic mechanisms involved in many otorhinolaryngological (ORL) chronic diseases. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients with chronic upper airways disease. The 1,817 (958 males, mean age 49 years) patients were evaluated at baseline (T0) and after one (T1) and two (T2) …

Maleupper airwaysupper airways exacerbated chronic disease thermal water hyaluronic acid grapefruit seed extractPlant Extractsexacerbated chronic diseasegrapefruit seed extractExacerbated chronic disease; Grapefruit seed extract; Hyaluronic acid; Thermal water; Upper airwaysthermal waterWaterMiddle AgedNOOtolaryngologyOtorhinolaryngologic DiseasesTreatment OutcomeEquipment and SuppliesRecurrenceHealth Care SurveysChronic DiseaseSeedshyaluronic acidHumansFemaleOriginal ArticleCitrus paradisiActa bio-medica : Atenei Parmensis
researchProduct

Sex differences in obstructive sleep apnoea.

2019

Obstructive sleep apnoea (OSA) and obstructive sleep apnoea/hypopnoea syndrome (OSAHS) have long been considered predominantly male-related conditions. The clinical presentation of sleep disordered breathing in females differs from males and can vary with age and physiological status,e.g.menopause and pregnancy. Overall, females appear to be more symptomatic, with lower apnoea–hypopnoea index scores compared to males. Furthermore, they appear to have more prolonged partial upper airway obstruction, and may report insomnia as a symptom of OSAHS more frequently. As a consequence of these differences in clinical presentation, females with sleep disordered breathing are often underdiagnosed and…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyPediatricsSettore MED/10 - Malattie Dell'Apparato Respiratorio030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineSex FactorsRisk FactorsEpidemiologymedicineInsomniaHumanslcsh:RC705-779PregnancySleep Apnea Obstructivewomen upper airways sleepbusiness.industrySleep apnealcsh:Diseases of the respiratory systemAirway obstructionmedicine.diseaseSleep in non-human animalsrespiratory tract diseasesMenopause030228 respiratory systemFemalePresentation (obstetrics)medicine.symptombusinessEuropean respiratory review : an official journal of the European Respiratory Society
researchProduct